Thinner Strut Sirolimus-Eluting BRS Versus EES in Patients With Coronary Artery Disease p FUTURE-II Trial

Song, L; Xu, B; Chen, YD; Zhou, YJ; Jia, SB; Zhong, ZX; Su, X; Ma, YT; Zhang, Q; Liu, J; Wang, Y; Guan, CD; Zheng, M; Qiao, SB; Gao, RL

Xu, B (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Cardiovasc Dis, Nat Ctr Cardiovasc Dis, Catheterizat Labs,Fu Wai Hosp, A 167 Beilishi Rd, Beijing 100037, Peoples R China.; Gao, RL (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Cardiovasc Dis, Nat Ctr Cardiovasc Dis, Dept Cardiol,Fu Wai Hosp, A 167 Beilishi Rd, Beijing 100037, Peoples R China.

JACC-CARDIOVASCULAR INTERVENTIONS, 2021; 14 (13): 1450

Abstract

OBJECTIVES The aim of the present study was to evaluate the safety and efficacy of thinner strut Firesorb (100/125 mm) sirolimus-eluting bioresorbable......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索